We are pleased to announce that we have launched a new production line that improves production capacity and flexibility to help maintain rapid delivery times.

Having its own internal production lines allows us to retain better control of lead times during both normal operations and during challenging time periods, such as the current worldwide component supply crisis.

Our in-house production facilities are equipped with the most-advanced Surface Mount Technology (SMT) machines, ensuring Modules in the highest standards and a wide range of customizations for every SoM. Variscite production is performed at fully ISO 13485, 9001 and 14001 compliant facilities, satisfying the international customer and regulatory requirements for various industries, including medical devices and related services. Fully integrated systems provide the critical components required to optimize product design, development and manufacturing.

We last placed a new line into production a year ago, making this the second production increase during the pandemic. The new internal production line is now online and ensures a rapid delivery within four working days.

Some of the other measures we’ve recently adopted to ensure stable and short deliveries to our clients include:

  • Early booking of components from the related material supplies and building in-house raw material buffers
  • Certifying alternate source for problematic components with long lead times and low availability
  • Optimizing production batches to build and supply products to its customers as soon as raw material is available
  • Leveraging platinum-level relationships with NXP and other long-term partners to ensure priority supply replenishments and secure stock.

“Thanks to Variscite’s rapid business decisions and full control over production, we were able to optimize our production capacity and optimize lead times during the entirety of the COVID pandemic that was followed by the worldwide semiconductors crisis,” said Ofer Austerlitz, VP Business Development and Sales of Variscite. “It required us to make adjustments and increase our agility but we did not stop our manufacturing at any point. The decision to bring additional production lines was part of the measures we adopted already in 2020 to ensure that manufacturing remains uninterrupted, allowing us to increase our production output while others face setbacks and delays”.